{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:11:42Z","timestamp":1790647902664,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2633,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ijid.2005.12.001","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T07:10:19Z","timestamp":1143529819000},"page":"193-201","source":"Crossref","is-referenced-by-count":132,"title":["Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy"],"prefix":"10.1016","volume":"10","author":[{"given":"Riccardo","family":"Wittek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2005.12.001_bib1","unstructured":"World Health Organization. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication, Geneva, December 1979. World Health Organization 1980, 1\u2013122."},{"issue":"Suppl. 2","key":"10.1016\/j.ijid.2005.12.001_bib2","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1201-9712(04)00133-X","article-title":"Smallpox containment updated: considerations for the 21st century","volume":"8","author":"Heymann","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/339909","article-title":"Shining light on \u201cDark Winter\u201d","volume":"34","author":"O\u2019Toole","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/375823","article-title":"Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome","volume":"37","author":"Amorosa","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib5","unstructured":"Ministry of Defence.1998. Available at: http:\/\/www.mod.uk\/issues\/gulfwar\/info\/medical\/bwa\/annexes\/annexii.htm."},{"key":"10.1016\/j.ijid.2005.12.001_bib6","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2005.12.001_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3201\/eid0403.980340","article-title":"Bioterrorism as a public health threat","volume":"4","author":"Henderson","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid0701.010125","article-title":"Strengthening national preparedness for smallpox: an update","volume":"7","author":"LeDuc","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0196-0644(03)00629-2","article-title":"Emergency medicine tools to manage smallpox (vaccinia) vaccination complications: clinical practice guideline and policies and procedures","volume":"42","author":"Thorne","year":"2003","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ijid.2005.12.001_bib10","unstructured":"Weaver JC. Smallpox vaccine: mandating risk to ward off an old enemy? American Health Consultants, ED Legal Letter, February 2003. Available at: http:\/\/www.ahcpub.com\/smallpox_article1_body.htm."},{"key":"10.1016\/j.ijid.2005.12.001_bib11","unstructured":"Alibek K, Handleman S. Biohazard. New York: Random House, 1999."},{"key":"10.1016\/j.ijid.2005.12.001_bib12","unstructured":"Leiberman J. Statement. United States Senate Committee on the Judiciary. BioShield II: Responding to An Ever Changing Threat. October 6, 2004. Available at: http:\/\/www.senate.gov\/comm\/judiciary\/general\/print_member_statement.cfm?id=1327&wit_id=3929."},{"key":"10.1016\/j.ijid.2005.12.001_bib13","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.12.001_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.otohns.2003.11.015","article-title":"Smallpox: what every otolaryngologist should know","volume":"130","author":"Tennyson","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijid.2005.12.001_bib15","unstructured":"McKinney WP, Bia FJ, Stewart C, Bosker G. Bioterrorism: an update for clinicians, pharmacists and emergency management planners. Emergency Medicine Consensus Reports. Consensus Panel Statements for Outcome-Effective and Evidence-Based Patient Management, Number 1. American Health Consultants, 2001. Available at: http:\/\/antibiotic-consult-pda.com\/articles\/bioterror.htm."},{"key":"10.1016\/j.ijid.2005.12.001_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1473-3099(03)00523-1","article-title":"Smallpox looms large \u2013 in life, and on the web","volume":"3","author":"Larkin","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib17","unstructured":"Ministry of Defence 2002. Available at: http:\/\/news.mod.uk\/news\/press\/news_press_notice.asp?newsItem_id=2225."},{"key":"10.1016\/j.ijid.2005.12.001_bib18","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.289.24.3278","article-title":"US military smallpox vaccination program experience","volume":"289","author":"Grabenstein","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijid.2005.12.001_bib19","first-page":"41","article-title":"The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox","volume":"25","author":"Kempe","year":"1961","journal-title":"Bull World Health Organ"},{"issue":"RR-7","key":"10.1016\/j.ijid.2005.12.001_bib20","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijid.2005.12.001_bib21","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-na\u00efve US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijid.2005.12.001_bib22","first-page":"889","article-title":"Smallpox vaccine: contraindications, administration, and adverse reactions","volume":"68","author":"Maurer","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijid.2005.12.001_bib23","unstructured":"Dryvax\u00ae Package Insert. Wyeth, 2004. Available at: http:\/\/www.fda.gov\/cber\/label\/smalwye110504LB.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib24","unstructured":"ACAM2000 Cell-culture derived smallpox vaccine. Available at: http:\/\/www.acambis.com\/default.asp?id=1218."},{"issue":"RR-4","key":"10.1016\/j.ijid.2005.12.001_bib25","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"53","author":"Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijid.2005.12.001_bib26","first-page":"1","article-title":"FDA role in counterterrorism: use of vaccinia immune globulins to treat adverse events after smallpox vaccine. Advisory Committee on Blood Safety and Availability","author":"Scott","year":"2002","journal-title":"DHHS"},{"key":"10.1016\/j.ijid.2005.12.001_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","article-title":"Complications of smallpox vaccination, 1968: results of ten statewide surveys","volume":"122","author":"Lane","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib28","unstructured":"FDA. Product approval information. Vaccinia Immune Globulin Intravenous (Human), Cangene Corporation. May 3, 2005. Available at: http:\/\/www.fda.gov\/cber\/products\/vigivcan050305.htm."},{"key":"10.1016\/j.ijid.2005.12.001_bib29","unstructured":"FDA. Product approval information. Vaccinia Immune Globulin Intravenous (Human), Dynport Vaccine Company. February 18, 2005. Available at: http:\/\/www.fda.gov\/cber\/products\/vigivdyn021805.htm."},{"key":"10.1016\/j.ijid.2005.12.001_bib30","unstructured":"Department of Health. Guidelines for smallpox response and management in the post-eradication era [Version 2], December 2, 2002. Available at: http:\/\/www.dh.gov.uk\/assetRoot\/04\/07\/08\/32\/04070832.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib31","unstructured":"Roth CE. WHO response to the threat of smallpox, and strategic vaccine reserves. In: Paul-Ehrlich-Institut, G7+ \u2013 Global Health Security Initiative (GHSI) Workshop. Best practices in vaccine production for smallpox and other potential pathogens. September 5\u20136, 2002. WHO 2003; 22\u20133. Available at: http:\/\/www.who.int\/csr\/disease\/smallpox\/en\/bestpractices.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib32","unstructured":"Hendriks J. Stockpiling of smallpox vaccines: the European Plan. In: Paul-Ehrlich-Institut. G7+ \u2013 Global Health Security Initiative (GHSI) Workshop. Best practices in vaccine production for smallpox and other potential pathogens. September 5\u20136, 2002. WHO, 2003; 22\u20133. Available at: http:\/\/www.who.int\/csr\/disease\/smallpox\/en\/bestpractices.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib33","first-page":"280","article-title":"Myocardial complications of immunisations","volume":"10","author":"Helle","year":"1978","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.ijid.2005.12.001_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.0954-6820.1983.tb03692.x","article-title":"Etiology of mild acute infectious myocarditis. Relation to clinical features","volume":"213","author":"Karjalainen","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ijid.2005.12.001_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijid.2005.12.001_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1542\/peds.26.2.176","article-title":"Studies on smallpox and complications of smallpox vaccination","volume":"26","author":"Kempe","year":"1960","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2005.12.001_bib37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/422999","article-title":"Clinical efficacy of intramuscular vaccinia immune globulin: a literature review","volume":"39","author":"Hopkins","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib38","unstructured":"Advisory Committee on Immunization Practices. Record of the February 2003 meeting, Atlanta. Available at: http:\/\/www.cdc.gov\/nip\/ACIP\/minutes\/acip-min-feb03.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","article-title":"Hyperimmune vaccinal gamma globulin. Source, evaluation, and use in prophylaxis and therapy","volume":"18","author":"Kempe","year":"1956","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2005.12.001_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/422998","article-title":"Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers","volume":"39","author":"Hopkins","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.12.001_bib41","unstructured":"Vaccinia Immune Globulin Intravenous (Human) (VIGIV) package insert. Cangene Corporation 2005. Available at: http:\/\/www.fda.gov\/cber\/label\/vigivcan050305LB.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib42","unstructured":"Vaccinia Immune Globulin (Human) package insert. Baxter Healthcare Corporation, 1995."},{"key":"10.1016\/j.ijid.2005.12.001_bib43","first-page":"317","article-title":"Prophylactic effect of antivaccinia gamma-globulin against post-vaccinial encephalitis","volume":"27","author":"Nanning","year":"1962","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2005.12.001_bib44","unstructured":"Data on File. Vaccinia Immune Globulin, Cangene Corporation. March 28, 2005."},{"key":"10.1016\/j.ijid.2005.12.001_bib45","unstructured":"Vaccinia Immune Globulin Intravenous (Human) (VIGIV) package insert. Dynport Vaccine Company 2005. Available at: http:\/\/www.fda.gov\/cber\/label\/vigivdyn021805LB.pdf."},{"key":"10.1016\/j.ijid.2005.12.001_bib46","unstructured":"WinRho SDF. Rh0 (D) Immune Globulin (Human) for injection package insert. Cangene Corporation, 2004."},{"key":"10.1016\/j.ijid.2005.12.001_bib47","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ajog.2004.07.014","article-title":"Pregnancy discovered after smallpox vaccination: is vaccinia immune globulin appropriate?","volume":"191","author":"Napolitano","year":"2004","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971206000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971206000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T17:45:46Z","timestamp":1683395146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971206000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1201971206000403"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2005.12.001","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}